Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, Francini G. Correale P, et al. Among authors: francini g. Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783. Br J Cancer. 2004. PMID: 15150625 Free PMC article. Clinical Trial.
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Petrioli R, Pascucci A, Conca R, Chiriacò G, Francini E, Bargagli G, Fiaschi AI, Manganelli A, De Rubertis G, Barbanti G, Ponchietti R, Francini G. Petrioli R, et al. Among authors: francini g, francini e. Br J Cancer. 2011 Feb 15;104(4):613-9. doi: 10.1038/bjc.2011.5. Epub 2011 Feb 1. Br J Cancer. 2011. PMID: 21285986 Free PMC article. Clinical Trial.
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study.
Petrioli R, Frediani B, Manganelli A, Barbanti G, De Capua B, De Lauretis A, Salvestrini F, Mondillo S, Francini G. Petrioli R, et al. Among authors: francini g. Cancer. 1996 Jan 15;77(2):344-51. doi: 10.1002/(SICI)1097-0142(19960115)77:2<344::AID-CNCR18>3.0.CO;2-1. Cancer. 1996. PMID: 8625244 Clinical Trial.
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.
Correale P, Messinese S, Marsili S, Ceciarini F, Pozzessere D, Petrioli R, Sabatino M, Cerretani D, Pellegrini M, Di Palma T, Neri A, Calvanese A, Pinto E, Giorgi G, Francini G. Correale P, et al. Among authors: francini g. Br J Cancer. 2003 Jul 21;89(2):239-42. doi: 10.1038/sj.bjc.6601045. Br J Cancer. 2003. PMID: 12865908 Free PMC article. Clinical Trial.
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Petrioli R, Sabatino M, Fiaschi AI, Marsili S, Pozzessere D, Messinese S, Correale P, Civitelli S, Tanzini G, Tani F, De Martino A, Marzocca G, Lorenzi M, Giorgi G, Francini G. Petrioli R, et al. Among authors: francini g. Br J Cancer. 2004 Jan 26;90(2):306-9. doi: 10.1038/sj.bjc.6601521. Br J Cancer. 2004. PMID: 14735168 Free PMC article. Clinical Trial.
Weekly chemotherapy in advanced prostatic cancer.
Francini G, Petrioli R, Manganelli A, Cintorino M, Marsili S, Aquino A, Mondillo S. Francini G, et al. Br J Cancer. 1993 Jun;67(6):1430-6. doi: 10.1038/bjc.1993.265. Br J Cancer. 1993. PMID: 8512828 Free PMC article. Clinical Trial.
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.
Correale P, Sciandivasci A, Intrivici C, Pascucci A, Del Vecchio MT, Marsili S, Savelli V, Voltolini L, Di Bisceglie M, Guarnieri A, Gotti G, Francini G. Correale P, et al. Among authors: francini g. Br J Cancer. 2007 May 7;96(9):1343-7. doi: 10.1038/sj.bjc.6603734. Epub 2007 Apr 17. Br J Cancer. 2007. PMID: 17437022 Free PMC article. Clinical Trial.
Weekly epirubicin in patients with hormone-resistant prostate cancer.
Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, Francini G. Petrioli R, et al. Among authors: francini g. Br J Cancer. 2002 Sep 23;87(7):720-5. doi: 10.1038/sj.bjc.6600525. Br J Cancer. 2002. PMID: 12232753 Free PMC article. Clinical Trial.
142 results